Feasibility, safety and cost-effectiveness of transjugular liver biopsy following major surgery in patients with haemophilia

Haemophilia

Volumn 13, Issue 5, 2007, Pages 588-592

  Detrait, M ^a   Pothen, D ^a   Brenard, R ^b   Starkel, P ^b   Hermans, Cedric ^b  

^a Haemostasis and Thrombosis Unit   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Continuous infusion; Haemophilia; Hepatitis C; Liver biopsy; Major surgery

Indexed keywords

BLOOD CLOTTING FACTOR 8; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ABDOMINAL SURGERY; ADULT; ARTICLE; BACTERIAL INFECTION; BLEEDING; BOLUS INJECTION; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; FEASIBILITY STUDY; HEALTH CARE COST; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEMOPHILIA A; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; INTERNAL JUGULAR VEIN; LENGTH OF STAY; LIVER BIOPSY; LIVER FUNCTION TEST; ORTHOPEDIC SURGERY; PATIENT SAFETY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; THORAX SURGERY; VIREMIA;

ADULT; BIOPSY; COSTS AND COST ANALYSIS; FEASIBILITY STUDIES; FEMALE; HEMOPHILIA A; HEPACIVIRUS; HEPATITIS C, CHRONIC; HOSPITALIZATION; HUMANS; JUGULAR VEINS; LIVER; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 34548317166     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2007.01515.x     Document Type: Article

References (25)

1. Aledort LM, Levine PH, Hilgartner M et al. A study of liver biopsies and liver disease among hemophiliacs. Blood 1985; 66: 367-72.
2. Hay CR, Preston FE, Triger DR, Greaves M, Underwood JC, Westlake L. Predictive markers of chronic liver disease in hemophilia. Blood 1987; 69: 1595-9.
3. Makris M, Preston FE, Rosendaal FR, Underwood JC, Rice KM, Triger DR. The natural history of chronic hepatitis C in haemophiliacs. Br J Haematol 1996; 94: 746-52.
4. Lang L. NIH consensus development conference updates HCV management. Gastroenterology 2002; 123: 404.
5. Fukuda Y, Nakano I, Katano Y et al. Assessment and treatment of liver disease in Japanese haemophilia patients. Haemophilia 1998; 4: 595-600.
6. Hanley JP, Jarvis LM, Andrews J et al. Investigation of chronic hepatitis C infection in individuals with haemophilia: Assessment of invasive and non-invasive methods. Br J Haematol 1996; 94: 159-65.
7. Lesesne HR, Morgan JE, Blatt PM, Webster WP, Roberts HR. Liver biopsy in hemophilia A. Ann Intern Med 1977; 86: 703-7.
8. McMahon C, Pilkington R, Shea EO, Kelleher D, Smith OP. Liver biopsy in Irish hepatitis C-infected patients with inherited bleeding disorders. Br J Haematol 2000; 109: 354-9.
9. Preston FE, Triger DR, Underwood JC et al. Percutaneous liver biopsy and chronic liver disease in haemophiliacs. Lancet 1978; 2: 592-4.
10. Ahmed MM, Mutimer DJ, Elias E et al. A combined management protocol for patients with coagulation disorders infected with hepatitis C virus. Br J Haematol 1996; 95: 383-8.
11. Dawson MA, McCarthy PH, Walsh ME et al. Transjugular liver biopsy is a safe and effective intervention to guide management for patient with a congenital bleeding disorder infected with hepatitis C. Intern Med J 2005; 35: 556-9.
12. DiMichele DM, Mirani G, Wilfredo Canchis P, Trost DW, Talal AH. Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection. Haemophilia 2003; 9: 613-8.
13. Farrell RJ, Smiddy PF, Pilkington RM et al. Guided versus blind liver biopsy for chronic hepatitis C: Clinical benefits and costs. J Hepatol 1999; 30: 580-7.
14. Fried MW. Management of hepatitis c in the hemophilia patient. Am J Med 1999; 107: 85S-89S.
15. Brenard R, Horsmans Y, Rahier J, Druez P, Descamps Ch, Geubel A. Transjugular liver biopsy. An experience based on 500 procedures. Acta gastroenterological Belgica 1997; 60: 138-41.
16. Ludwig J. The nomenclature of chronic active hepatitis: An obituary. Gastroenterology 1993; 105: 274-8.
17. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C the metavir cooperative study group. Hepatology 1996; 24: 289-93.
18. Shin JL, Teitel J, Swain MG et al. Virology and Immunology Committee of the Association of Hemophilia Clinic Directors of Canada. A Canadian multicenter retrospective study evaluating transjugular liver biopsy in patients with congenital bleeding disorders and hepatitis C: Is it safe and useful? Am J Hematol 2005; 78: 85-93.
19. Stieltjes N, Ounnoughene N, Sava E et al. Interest of transjugular liver biopsy in adult patients with haemophilia or other congenital bleeding disorders infected with hepatitis C virus. Br J Haematol 2004; 125: 769-76.
20. Venkataramani A, Behling C, Rond R, Glass C, Lyche K. Liver biopsies in adult hemophiliacs with hepatitis C: A United States center's experience. Am J Gastroenterol 2000; 95: 2374-6.
21. White GC II, Zeitler KD, Lesesne HR et al. Chronic hepatitis in patients with hemophilia A: Histologic studies in patients with intermittently abnormal liver function tests. Blood 1982; 60: 1259-62.
22. Wong VS, Baglin T, Beacham E, Wight DD, Petrik J, Alexander GJ. The role for liver biopsy in haemophiliacs infected with the hepatitis C virus. Br J Haematol 1997; 97: 343-7.
23. Lethagen S, Widell A, Berntorp E, Verbaan H, Lindgren S. Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease. Br J Haematol 2001; 113: 87-93.
24. Makris M, Preston FE, Triger DR, Underwood JC, Westlake L, Adelman MI. A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacs. Blood 1991; 78: 1672-7.
25. Posthouwer D, Mauser-Bunschoten EP, fischer K, Makris M. Treatment of chronic hepatitis C in patients with haemophilia: A review of literature. Haemophilia 2006; 12: 473-8.